National Bank of Canada
BLFS

National Bank of Canada’s BioLife Solutions BLFS Stock Holding History

National Bank of Canada’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-127
Closed -$2.42K – 3144
2026
Q1 		$2.42K Buy
+127
New +$2.81K ﹤0.01% 2591

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

National Bank of Canada's BLFS Position: Q2 2026 in Review

National Bank of Canada sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 127 shares — an estimated $2.42K sold.

National Bank of Canada first reported a position in BLFS in Q1 2026 and held it in 1 quarter. The position peaked at $2.42K in Q1 2026. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • National Bank of Canada reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • National Bank of Canada sold 127 BioLife Solutions shares in Q2 2026, an estimated $2.42K.
  • National Bank of Canada first reported a position in BioLife Solutions in Q1 2026 and held it in 1 quarter.
  • National Bank of Canada's BioLife Solutions position peaked at $2.42K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.